A second dose of the J&J vaccine was recommended for everyone who received their first dose at least two months ago.
Last Thursday night, The director of the Centers for Disease Control and Prevention signed off on mix-and-match COVID-19 booster shots
The committee said it could increase protection against the disease that is killing on average 1,093 Americans a day. A CDC advisory committee recommended Thursday afternoon that Americans be allowed to choose among the Pfizer-BioNTech, Moderna and Johnson & Johnson vaccines as a COVID-19 booster shot.
CDC Director Dr. Rochelle Walensky said in a statement, “The evidence shows that all three COVID-19 vaccines authorized in the United States are safe – as demonstrated by the over 400 million vaccine doses already given. And, they are all highly effective in reducing the risk of severe disease, hospitalization, and death”
Pick any vaccine: CDC OKs COVID boosters – even mixing and matching- since last Friday
Americans are now free to get a free booster dose of all three COVID-19 vaccines, and can even choose to mix and match their vaccines, after the director of the Centers for Disease Control and Prevention signed off on new recommendations Thursday night.
Today, the U.S. Food and Drug Administration took action to expand the use of a booster dose for COVID-19 vaccines in eligible populations. The agency is amending the emergency use authorizations (EUA) for COVID-19 vaccines to allow for the use of a single booster dose as follows:
- The use of a single booster dose of the Moderna COVID-19 Vaccine that may be administered at least 6 months after completion of the primary series to individuals:
- 65 years of age and older
- 18 through 64 years of age at high risk of severe COVID-19
- 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2
- The use of a single booster dose of the Janssen (Johnson and Johnson) COVID-19 Vaccine may be administered at least 2 months after completion of the single-dose primary regimen to individuals 18 years of age and older.
- The use of each of the available COVID-19 vaccines as a heterologous (or “mix and match”) booster dose in eligible individuals following completion of primary vaccination with a different available COVID-19 vaccine.
- To clarify that a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine may be administered at least 6 months after completion of the primary series to individuals 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2.
- In the US, 501,613,665 doses have been distributed so far, with 82% or 411,963,025 of the doses used.
- At least 219,900,525 people or 67% of the population have received at least one dose.
- Overall, 190,179,553 people or 58% of the population have been fully vaccinated.
Find COVID-19 Vaccine Near You
Find a COVID-19 Vaccine: Search vaccines.gov, text your ZIP code to 438829, or call 1-800-232-0233 to find locations near you in the U.S.
1 If you have had a severe allergic reaction (anaphylaxis) or an immediate allergic reaction to any ingredient in the vaccine you are scheduled to receive, you should not get that vaccine. If you have been instructed not to get one type of COVID-19 vaccine, you may still be able to get another type. Learn more information for people with allergies.
2 You should get your second shot as close to the recommended 3-week or 4-week interval as possible. However, your second shot may be given up to 6 weeks (42 days) after the first dose, if necessary.
To learn more about U.S. COVID-19 vaccine clinical trials, including vaccines in earlier stages of development, by visiting clinicaltrials.gov.external icon
Covid-19 and Travel Updates
For COVID-19 travel information worldwide, check your status updates and requirement with Timatic Widget.
For United States Citizens, check here
Also check COVID-19 Travel Restrictions and Exceptions
WASHINGTON, (Reuters) – The United States will reopen in November to air travelers from 33 countries including China, India, Brazil and most of Europe who are fully vaccinated against COVID-19.